Abstract:Background. RNA interference (RNAi), which has been demonstrated as having great potentional in the fields of gene function and gene therapy, was applied to inhibit the expression of some endogenous genes. Human telomerase reverse transcriptase (hTERT) is highly expressed in hepatocellular carcinoma cells.Materials and methods. In combination with DNA vector-based RNAi, quantitative real-time reverse transcription polymerase chain reaction, telomeric repeat amplification protocol-enzyme-linked immunosorbent assay, 3-(4,5 dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide assay, and xenograft tumor annual techniques, we first constructed three pTZU6 + 1-shRNA-hTERT vectors and their corresponding site-mutated vectors, then transfected them into hepatocarcinoma HepG2, SMMC-7721 cells, and normal liver L02 cells, respectively, injected them into xenograft hepatocarcinoma tumor tissues to induce RNAi, and then detected the alteration of cell and tumor proliferation, telomerase activity, hTERT, and c-myc expression in each treatment.Results. The cell proliferation of hepatocellular carcinoma cells both in vitro and in vivo was significantly inhibited by ph1-shRNA, the most effective segment targeted hTERT gene. ph1-shRNA could inhibit telomerase activity, hTERT, and c-myc expression in hepatocarcinoma cells and xenograft tumor tissues compare with the cells treated with empty vector pTZU6 + 1. However, there were no obvious effects on normal liver L02 cells. Moreover, even a single base mutation in siRNAs transcription template would significantly reduce the ability of siRNAs to induce RNA silencing.Conclusions. RNAi-hTERT could inhibit the proliferation of hepatocarcinoma cells specifically via the suppression of telomease activity, hTERT, and c-myc expression. Therefore, hTERT and c-myc play key roles in hepatocarcinoma tumorgenesis, and an RNAi-targeted hTERT strategy would be a potential approach for hepatocarcinoma therapy. (c) 2006 Elsevier Inc. All rights reserved.

Inhibition Of Telomerase Activity In Cancer Cells Using Short Hairpin Rna Expression Vectors

RNAi-hTERT Inhibition Hepatocellular Carcinoma Cell Proliferation Via Decreasing Telomerase Activity

Shrna-Targeted Htert Suppress Cell Proliferation of Bladder Cancer by Inhibiting Telomerase Activity

Lentiviral Mir30-Based Rna Interference Against Heparanase Suppresses Melanoma Metastasis With Lower Liver And Lung Toxicity

Inhibitory Effect of Silencing Htert Gene on Growth of Human Squamous Cell Carcinoma Xenograft in Nude Mice

hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells.

Tumor-targeted Efficiency of Shrna Vector Harboring Chimera Htert/u6 Promoter.

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

Antisense Htert Inhibits Thyroid Cancer Cell Growth.

BC047440 Gene Silencing Inhibits the Proliferation of HepG2 Cells

The effect of short hairpin RNA on hTERT expression]

[The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells].

Inhibitory Effect of Sirna Targeted at Telomerase of Hepatocellular Carcinoma(hepg2)transfected by Lentivirus in Vitro

Antitumor Efficacy of Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide in Pancreatic Cancer Cells.

[A DNA Vector-Based RNAi Technology to Inhibit the Activity of the Telomerase of Cell Line HCCLM3].

Stable Expression of Antisense Htr Inhibits in Vitro Pancreatic Cancer Cell Growth.

Intensive Inhibition of Htert Expression by a Ribozyme Induces Rapid Apoptosis of Cancer Cells Through a Telomere Length Independent Pathway

Effects of Htert Sirna on Expression of Htert and Repression of Cell Growth in Breast Cancer Cells

[Effects of Epidermal Growth Factor Receptor Gene Silencing Mediated by Short Hairpin RNA on Proliferation and Apoptosis of Human Tongue Carcinoma Cells].

The experimental study of short hairpin RNA on the suppression of lung cancer-associated gene

Inhibition of Bcl-2 Expression by a Novel Tumor-Specific RNA Interference System Increases Chemosensitivity to 5-Fluorouracil in Hela Cells